CLPT Valuation

Clearpoint Neuro Inc

Add to Watchlist

Advanced Chart

14.430

+0.520(+3.740%)

Overview
Forecast
Valuation

CLPT Relative Valuation

CLPT's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, CLPT is overvalued; if below, it's undervalued.

Historical Valuation

Clearpoint Neuro Inc (CLPT) is now in the Fair zone, suggesting that its current forward PS ratio of 10.56 is considered Fairly compared with the five-year average of 10.97. The fair price of Clearpoint Neuro Inc (CLPT) is between 6.32 to 19.96 according to relative valuation methord.

Relative Value

Fair Zone

6.32-19.96

Current Price：14.43

Fair

Trailing

Forward

P/E

EV/EBITDA

EV/EBIT

P/S

P/OCF

P/FCF

Trailing

Forward

15.70

P/B

Median3y

7.79

Median5y

64.72

-2.28

FCF Yield

Median3y

-6.95

Median5y

-5.97

Competitors Valuation Multiple

The average P/S ratio for CLPT's competitors is 3.65, providing a benchmark for relative valuation. Clearpoint Neuro Inc Corp (CLPT) exhibits a P/S ratio of 10.56, which is 189.24% above the industry average. Given its robust revenue growth of 14.11%, this premium appears unsustainable.

P/S

P/E

EV/EBITDA

EV/EBIT

P/S

Revenue Growth

Market Cap